Back

Infectious Diseases and Therapy

18 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Efficacy and safety of newer antibiotics versus generic antibiotics for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trials
2026-02-12 infectious diseases 10.64898/2026.02.11.26345978
Top 0.3% (1.2%)
Show abstract

BackgroundHospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), particularly those caused by multi-drug resistant organisms (MDROs), often require newer antibiotic treatment. The efficacy and safety of newer antibiotics compared to generic antibiotics in randomized controlled trials (RCTs) have not been evaluated before. MethodsIn this systematic review, we searched RCTs in the United States National Library of Medicine (PubMed), Cochrane Central Reg...

2
Antibiotic coverage in biliary-stented pancreatoduodenectomy: Real-world evidence supporting piperacillin tazobactam over ampicillin sulbactam
2026-02-14 infectious diseases 10.64898/2026.02.12.26346173
Top 0.6% (0.9%)
Show abstract

BackgroundPreoperative biliary stenting alters biliary colonization and may reduce the effectiveness of perioperative antibiotic prophylaxis in pancreatoduodenectomy. Although broader-spectrum regimens have been associated with improved infectious outcomes, their microbiological adequacy in routine clinical practice remains poorly defined. We therefore evaluated the real-world adequacy of a prolonged ampicillin-sulbactam protocol, its association with infectious outcomes and survival, and the po...

3
Admission Predictors of In-Hospital Mortality and the Combined Outcome of Death or Invasive Mechanical Ventilation in Patients with COVID-19 During the Pre-Vaccination Era: A Retrospective Cohort Study
2026-03-03 infectious diseases 10.64898/2026.02.28.26347308
Top 2% (0.5%)
Show abstract

BackgroundReliable identification of early predictors of adverse outcomes was essential during the pre-vaccination phase of the COVID-19 pandemic. Few studies have comprehensively integrated clinical presentation, laboratory parameters including arterial blood gas analysis, and chest computed tomography (CT) findings within a single well-characterized cohort, particularly in underrepresented regions of Brazil. MethodsThis retrospective cohort study included 482 consecutive adults (median age 61...

4
Reclaiming health: a qualitative, explorative study of long covid recovery journeys involving mind-body approaches.
2026-02-23 infectious diseases 10.64898/2026.02.21.26345052
Top 2% (0.5%)
Show abstract

ObjectiveThis study explored the recovery experiences of individuals who report having (largely) recovered from long covid and who attributed their improvement to mind-body approaches. Design, setting and participantsWe conducted an explorative qualitative study using purposive recruitment through social media and snowball sampling. Eighteen adult women (aged 37-62 years), who self-identified as having had long covid and having substantially recovered through mind-body approaches participated i...

5
Changes In Incidence And Serotype Distribution Of Pediat-Ric Invasive Pneumococcal Disease After The Introduction Of 15-Valent Pneumococcal Conjugate Vaccine In Catalo-Nia, Spain. A Multicenter Surveillance Study
2026-02-12 epidemiology 10.64898/2026.02.11.26346066
Top 2% (0.4%)
Show abstract

BackgroundSerotype 3 (S3) has remained a major cause of invasive pneumococcal disease (IPD) despite its inclusion in 13-valent pneumococcal conjugate vaccine (PCV). In October 2023, a 15-valent PCV (PCV15) including S3 was introduced into the Catalan universal childhood immunization program. MethodsWe conducted a retrospective pre-post surveillance study to compare pediatric IPD incidence in Catalonia during a pre-PCV15 period (October 1, 2022-September 30, 2023) and two post-PCV15 periods (Oct...

6
All text: A Novel Scoring System for Precise Severity Quantification in Severe Fever with Thrombocytopenia Syndrome: Development and Application Based on Dynamic Clinical Data
2026-02-18 infectious diseases 10.64898/2026.02.17.26346452
Top 2% (0.4%)
Show abstract

BackgroundSevere Fever with Thrombocytopenia Syndrome (SFTS) is an acute infectious disease with high mortality. This study aimed to develop a quantitative scoring system for grading SFTS severity using dynamic clinical data. MethodsA retrospective study included 547 confirmed SFTS patients from two hospitals. Clinical data were collected over a 14-day course (divided into four phases). Patients were grouped into survivors (n=451) and non-survivors (n=96). Statistical analyses, including Kaplan...

7
Immunogenicity and safety of LP.8.1 variant-containing mRNA COVID-19 vaccines
2026-02-26 infectious diseases 10.64898/2026.02.24.26346954
Top 2% (0.4%)
Show abstract

BackgroundThe SARS-CoV-2 LP.8.1 subvariant was incorporated into the 2025-2026 U.S. COVID-19 vaccines (mRNA-1273.251 and mRNA-1283.251). We evaluated immunogenicity and safety of these vaccines against vaccine-matched and emerging variants in individuals aged [≥]65 and those aged 12-64 years at high-risk of severe COVID-19. MethodsData were generated from: (1) two independent, ongoing, phase 3b/4, open-label, single-arm studies in which participants received a single dose of 50-{micro}g mRNA...

8
Risk of new-onset obstructive sleep apnea up to 4.5 years after COVID-19 in the urban population.
2026-02-15 infectious diseases 10.64898/2026.02.12.26346136
Top 2% (0.4%)
Show abstract

RationaleObstructive sleep apnea (OSA) is linked to cardiovascular, metabolic, and cognitive morbidity. Although COVID-19 has been associated with long-term respiratory and neurological sequelae, its role in precipitating new-onset OSA remains unclear. ObjectivesTo evaluate whether SARS-CoV-2 infection increases risk of developing OSA up to 4.5 years post-infection and how risk varies by hospitalization status, demographics, comorbidities, and vaccination status. MethodsThis retrospective coho...

9
Quantifying the association between neutralising antibodies and protection from RSV disease in infants and adults: A systematic review and meta-analysis
2026-02-15 infectious diseases 10.64898/2026.02.13.26346212
Top 3% (0.4%)
Show abstract

A number of vaccines and long-acting monoclonal antibodies have been shown to be effective in the prevention of respiratory syncytial virus (RSV) disease. However, an immune correlate of protection for RSV has not yet been identified. We conducted a systematic review to identify published reports of immunogenicity and/or efficacy in vaccines and long-acting monoclonal antibodies against RSV and performed a meta-analysis on extracted data to identify any relationship between antibody increase and...

10
Two-step deep-learning candidemia prediction model using two large time-sequence electronic health datasets
2026-03-04 infectious diseases 10.64898/2026.03.03.26347531
Top 3% (0.4%)
Show abstract

BackgroundCandidemia is a rare but life-threatening bloodstream infection that remains difficult to predict using conventional risk stratification approaches, highlighting the need for improved predictive strategies. As a result, empiric antifungal therapy is often delayed even in high-risk patients. MethodsWe developed a deep learning model (PyTorch_EHR) to predict 7-day candidemia risk by using electronic health record data from two large cohorts (Houston Methodist Hospital System [HMHS] and ...

11
Associations between SARS-CoV-2 Infection and Multidimensional Sleep Health
2026-02-25 infectious diseases 10.64898/2026.02.19.26346546
Top 3% (0.4%)
Show abstract

PuhrposeTo evaluate the short- and long-term cross-sectional associations between COVID-19 infection and multidimensional sleep health. MethodsData from the COVID-19 Outbreak Public Evaluation (COPE) initiative were used to examine the association between a novel multidimensional sleep health measure (COPE Multidimensional Sleep Health Scale, CMSHS) modeled from the RuSATED instrument and (1) COVID-19 infection and (2) post-acute sequelae of SARS-CoV-2 infection (PASC). ResultsData from 11,326...

12
Diagnostic Accuracy of an Immunoassay Using Avidity-Enhanced Polymeric Peptides for SARS-CoV-2 Antibody Detection
2026-03-02 infectious diseases 10.64898/2026.02.26.26343835
Top 3% (0.4%)
Show abstract

BackgroundThere is a need for synthetic peptide-based serologic assays that exploit avidity to replace whole antigens while enabling low-cost diagnostics in resource-limited settings. ObjectiveTo evaluate the diagnostic accuracy of a polymeric peptide-based ELISA leveraging avidity to enhance signal. MethodA 15-member SARS-CoV-2 peptide library corresponding to multiple epitope clusters and proteins was screened by indirect ELISA using pooled sera from RT-PCR-confirmed COVID-19 patients to ide...

13
Paediatric meningoencephalitis in the molecular diagnostic era: Epidemiological insights from 1,198 suspected cases in Germany between 2016 and 2024
2026-02-22 infectious diseases 10.64898/2026.02.15.26346341
Top 4% (0.4%)
Show abstract

BackgroundThe epidemiology of suspected pediatric meningoencephalitis has shifted in the era of conjugate vaccines and multiplex PCR diagnostics, with viral pathogens now predominating over bacterial causes. Updated epidemiologic data are essential to adapt diagnostic and therapeutic algorithms to current clinical practice. MethodsThis retrospective single-center study included children and adolescents <18 years who underwent lumbar puncture with cerebrospinal fluid multiplex PCR for suspected ...

14
An online, open-access, cost comparison tool for presumptive tuberculosis testing using low complexity, automated, nucleic acid amplification tests (LCaNAAT) versus near point-of-care (NPOCs) molecular tests
2026-02-18 infectious diseases 10.64898/2026.02.17.26346475
Top 4% (0.3%)
Show abstract

The world is far from achieving universal access to rapid tuberculosis (TB) diagnostics that align with World Health Organization (WHO) diagnostic standards. Although WHO-recommended molecular rapid diagnostics (mWRDs), including low-complexity automated nucleic acid amplification tests (LCaNAAT), have significantly improved TB detection, scale-up has been constrained by high capital, maintenance, and consumable costs. Recently, lower-cost, near-point-of-care nucleic acid amplification tests (NP...

15
Influenza Vaccine Effectiveness Against Pediatric Deaths: 2016-2025
2026-02-22 infectious diseases 10.64898/2026.02.20.26346732
Top 4% (0.3%)
Show abstract

BACKGROUND AND OBJECTIVESSeasonal influenza vaccination has been shown to reduce the risk of influenza and severe complications among children 6 months and older. Since 2010, reported numbers of influenza-associated pediatric deaths among children aged <18 years have ranged from 37 during the 2011-2012 season to 289 during 2024-2025. We estimated influenza vaccine effectiveness (VE) against pediatric death from 2016-2017 through 2024-2025. METHODSWe conducted a case-cohort analysis comparing cu...

16
Comparative Analysis of Biofilm Formation in Bacterial and Fungal Isolates from Contact Lens and Non-Contact Lens Associated Keratitis
2026-02-09 infectious diseases 10.64898/2026.02.09.26345896
Top 5% (0.3%)
Show abstract

Microbial keratitis is a sight-threatening corneal infection with varying etiological agents, primarily bacteria and fungi. Assessing and contrasting the virulence factors of microorganisms isolated from a non-contact lens-associated keratitis (NCLAK) and contact lens-associated keratitis (CLAK) is the goal of the current investigation. Samples were collected from over 60 patients and analysed using standard microbiological techniques, including culture, Gram staining, KOH mount, biochemical tes...

17
Hemophagocytic lymphohistiocytosis (HLH) in 2025 Dengue outbreak in Chittagong, Bangladesh
2026-02-17 infectious diseases 10.64898/2026.02.14.26346308
Top 5% (0.3%)
Show abstract

IntroductionHemophagocytic lymphohistiocytosis (HLH) is a serious condition induced by Dengue virus which becomes fatal if not detected early and treated appropriately. So objectives of the present study are to observe the different patterns of presentations, clinical features and outcome of HLH induced by Dengue. MethodsIn this observational study, 14 patients admitted and diagnosed HLH as per diagnostic criteria, were included after informed written consent. Study conducted in a period of six...

18
Digital Adherence Support for Tuberculosis Treatment: A Multicentre Randomized Trial in Kenya
2026-02-14 infectious diseases 10.64898/2026.02.11.26346015
Top 5% (0.3%)
Show abstract

BackgroundImproving tuberculosis (TB) treatment success is critical for improving the health of individuals with TB, reducing transmission, and lowering treatment costs. We conducted a four-arm randomized controlled trial (RCT) to evaluate whether three digital interventions with increasing support improved treatment outcomes compared to the standard of care. MethodsIn this open-label, parallel RCT in Kenya, all TB patients at 902 participating clinics who had at least 2 months of treatment rem...

19
Costs and cost-effectiveness of an infection prevention bundle to reduce neonatal sepsis and mortality in Zambia: The Sepsis Prevention in Neonates in Zambia (SPINZ) trial
2026-02-12 infectious diseases 10.64898/2026.02.04.26345617
Top 5% (0.3%)
Show abstract

The Sepsis Prevention in Neonates in Zambia (SPINZ) trial was a prospective observational cohort study conducted in the neonatal intensive care unit of the University Teaching Hospital in Lusaka, Zambia. Introduction of an infection prevention and control (IPC) bundle reduced hospital-associated mortality, total mortality, suspected sepsis, and confirmed bloodstream infections. This companion analysis was undertaken to analyze intervention costs and cost-effectiveness in this low-resource settin...

20
Respiratory Infection Burden and Work Attendance among Healthcare Workers; The CHILL Study (Common Cold Healthcare Workers Immunological Longitudinal Learning)
2026-02-19 infectious diseases 10.64898/2026.02.18.26346598
Top 6% (0.3%)
Show abstract

ObjectiveTo quantify the seasonal burden of acute respiratory viral infections among healthcare workers (HCWs), characterize virologic etiologies, and identify predictors of symptomatic illness and sick leave. MethodsWe conducted a prospective cohort study of HCWs during winter 2024-2025, with weekly surveys capturing acute respiratory infections (ARI) and sick leave. Nasal-throat multiplex PCR swabs were self-collected during symptomatic episodes. Incidence rate ratios (IRRs) for symptomatic e...